Probiotics in dairy foods: A review

Nutrition and Food Science

Volumn 44, Issue 1, 2014, Pages 71-88

  Khan, Shahnawaz Umer ^a  

^a SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

Author keywords

Consumers; Dairy foods; Health; Probiotics

Indexed keywords

EID: 84893274862     PISSN: 00346659     EISSN: None     Source Type: Journal    
DOI: 10.1108/NFS-04-2013-0051     Document Type: Review

References (84)

1. Balansky, R., Gyosheva, B., Ganchev, G., Mircheva, Z., Minkova, S., Georgiev, G. (1999), "Inhibitory effects of free-dried milk fermented by selected Lactobacillus bulgaricus strains on carcinogenesis induced by 1, 2-dimethylhydrazine in rats and by diethylnitrosarnine in hamsters" in Cancer Lett., Vol. 147, pp. 125-137.
2. Barefoot, S.F., Klaenhammer, T.R. (1983), "Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus" in Appl. Environ. Microbiol., Vol. 45, pp. 1808-1815.
3. Challa, A., Rao, D.R., Chawan, C.B., Shackelford, L. (1997), "Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats" in Carcinogenesis, Vol. 18, pp. 517-521.
4. Chandan, R.C. (1999), "Enhancing market value of milk by adding cultures" in J. Dairy Sci., Vol. 82, pp. 2245-2256.
5. De Vuyst, L., Vandamme, E.J. (1994), "Antimicrobial potential of lactic acid bacteria" in De Vuyst, L. and Vandamme, E.J. (Eds.), Bacteriocins of Lactic Acid Bacteria, Blackie Academic and Professional, Glasgow, pp. 91-142.
6. Gallaher, D.D., Khil, J. (1999), "The effect of synbiotics on colon carcinogenesis in rats" in J. Nutr., Vol. 129, pp. 1483-1487.
7. Gallaher, D.D., Satllings, W.H., Blessing, L.L., Busta, F.F., Brady, L.J. (1996), "Probiotics, cecal microflora and aberrant crypts in the rat colon" in J. Nutr., Vol. 126, pp. 1362-1371.
8. Gardiner, G., Stanton, C., Lynch, P.B., Collins, J.K., Fitzgerald, G., Ross, R.P. (1999), "Evaluation of cheddar cheese as a food carrier for delivery of a probiotic strain to the gastrointestinal tract" in J. Dairy Sci., Vol. 82, pp. 1379-1387.
9. Gill, C., Rowland, L. (2003), "Cancer" Matti1a-Sandholm, T. and Saarela, M. (Eds.), Functional Dairy Products, CRC Press, Cambridge, MA.
10. Gilliland, S.E., Speck, M.L. (1977), "Antagonistic action of Lactobacillus acidophilus toward intestinal and foodborne pathogens in associative cultures" in J. Food Prot., Vol. 40, pp. 820-823.
11. Gilliland, S.E., Walker, D.K. (1990), "Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans" in J. Dairy Sci., Vol. 73, pp. 905-911.
12. Gilliland, S.E., Nelson, C.R., Maxwell, C. (1985), "Assimilation of cholesterol by Lactobacillus acidophilus" in Appl. Environ. Microbiol., Vol. 49, pp. 377-381.
13. Gilliland, S.E., Speck, M.L., Nauyok, G.F. Jr, Giesbrecht, F.G. (1978), "Influence of consuming non-fermented milk containing Lactobacillus acidophilus on the fecal flora of healthy males" in J. Dairy Sci., Vol. 61, pp. 1-10.
14. Goldin, B.R., Gorbach, S.L. (1980), "Effect of Lactobacillus acidophilus dietary supplements on 1, 2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats" in J. Natl Cancer Inst., Vol. 64, pp. 263-265.
15. Goldin, B.R., Gorbach, S.L. (1984a), "Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides" in J. Natl Cancer Inst., Vol. 73, pp. 689-695.
16. Goldin, B.R., Gorbach, S.L. (1984b), "The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity" in Am. J. Clin. Nutr., Vol. 39, pp. 756-761.
17. Goldin, B.R., Gorbach, S.L. (1984c), "The effect of oral administration of Lactobacillus and antibiotics on intestinal bacterial activity and chemical induction of large bowel tumors" in Dev. Ind. Microbiol., Vol. 25, pp. 139-150.
18. Goldin, B.R., Swenson, L., Dwyer, J., Sexton, M., Gorbach, S. (1980), "Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes" in J. Natl Cancer Inst., Vol. 64, pp. 255-261.
19. Greene, J.D., Klaenhammer, T.R. (1994), "Factors involved in adherence of lactobacilli to human Caco-2 cells" in Appl. Environ. Microbiol., Vol. 60, pp. 4487-4494.
20. Guerrero, M., Dohnalek, M., Newton, P., Kuznetsova, O., Murphy, T., Calva, J., Hilty, M., Costigan, T., Ruiz-Palacios, G. (1996b), "Effect of probiotic-containing beverages on incidence of diarrhea", Vol. 610, Abstracts of the 1st World Congress of Pediatric Infectious Diseases, 15th Inter American Congress of Pediatric Infectious Diseases, Acapulco, Mexico.
21. Haza, A.I., Zabala, A., Morales, P. (2004), "Protective effect and cytokine production of a Lactobacillus plantarum strain isolated from ewes' milk cheese" in Int. Dairy J., Vol. 14, pp. 29-38.
22. Hirayama, K., Rafter, L. (1999), "The role of lactic acid bacteria in colon cancer prevention: mechanistic consideration" in Antonie van Leeuwenhoek, Vol. 76, pp. 391-394.
23. Hirayama, K., Rafter, L. (2000), "The role of probiotic bacteria in cancer prevention" in Microbes and Infection, Vol. 2, p. 681.
24. Ishibashi, N., Shimamura, S. (1993), "Bifidobacteria: research and development in Japan" in Food Technol., Vol. 46, pp. 126-135.
25. Iturriria-Laverty, K., Tong, P.S., Sanders, M.E. (1999), "Microbiological stability of probiotic and starter bacteria in commercial yogurt and cottage cheese" in J. Dairy Sci., Vol. 82, Suppl. 1, p. 6.
26. Iwana, H., Masuda, H., Fujisawa, T., Suzuki, H., Mitsouka, T. (1993), "Isolation of Bifidobacterium spp. in commercial yoghurts sold in Europe" in Bifidobacteria and Microflora, Vol. 12, pp. 39-45.
27. Jain, M. (1998), "Dairy foods, dairy fats and cancer: a review of epidemiological evidence" in Nutr. Res., Vol. 18, pp. 905-937.
28. Juillard, V., Spinnler, H.E., Desmazeaud, M.J., Boquien, C.Y. (1987), "Phénoménes de cooperation et d'inhibition entre les bacté- ries lactiques utilices en industrie laitiéreé" in Lait., Vol. 67, No. 2, pp. 149-172.
29. Kailasapathy, K., Rybka, S. (1997), "L. acidophilus and Bifidobacterium spp. - their therapeutic potential and survival in yogurt" in The Australian Journal of Dairy Technology, Vol. 52, pp. 28-35.
30. Knasmüller, S., Steinkellner, H., Hirschi, A.M., Rabot, S., Nobis, E.C., Kassie, F. (2001), "Impact of bacteria in dairy products and of the intestinal rnicroflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines" in Mut. Res., Vol. 129, pp. 480-481.
31. Kneifel, W., Jaros, D., Erhard, F. (1993), "Microflora and acidification properties of yogurt and yogurt-related products fermented with commercially available starter cultures" in International Journal of Food Microbiology, Vol. 18, pp. 179-189.
32. Kulkarni, N., Reddy, B.S. (1994), "Inhibitory effect of Bifidobacterium longum cultures on the azoxyrnethane-induced aberrant crypt foci formation and fecal bacterial p-glucuronidase" in Proc. Soc. Exp. Biol. Med., Vol. 207, pp. 278-283.
33. Lee, S.M., Lee, W.K. (2000), "Inhibitory effects oflactic acid bacteria (LAB) on the azoxyrnethaneinduced colonic preneoplastic lesions" in J. Microbiol., Vol. 38, p. 169.
34. Lee, Y.K., Salminen, S. (1995), "The coming of age of probiotics" in Trends Food Sci. Technol., Vol. 6, pp. 241-245.
35. Ling, W.H., Korpela, R., Mykkanen, H., Salminen, S., Hanninen, O. (1994), "Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults" in Nutr., Vol. 124, pp. 18-23.
36. Manjwlath, N., Ranganathan, B. (1989), "A cytotoxic substance produced by a wild culture of Lactobacillus casei D-34 against tumor cells" in Indian J. Exp. Bio., Vol. 27, pp. 141-145.
37. Matsulloto, M., Berulo, Y. (2004), "Consumption of Bifidobacterium lactis LKM5l2 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects" in Mutat. Res., Vol. 568, pp. 147-153.
38. Mercenier, A., Pavan, S., Pot, B. (2003), "Probiotic as biotherapeutic agents: present knowledge and future prospects" in Curr. Pharm. Des., Vol. 8, pp. 99-110.
39. Miettinen, M., Vuopio, J., Varkila, K. (1996), "Production of human tumor necrosis factor α, interleukin-6, and interleukin-10 is induced by lactic acid bacteria" in Infect. Immun., Vol. 64, pp. 5403-5410.
40. NLAB (2002), "The production of mixed starters containing Lactococci, Lactobacilli and Leuconostoc in commercial media", Research Network on Lactic Acid Bacteria, Dairy Research Centre STELA, available at: www.fsaa.ulaval.ca/stelawww/en/pdf/technofiche3a.pdf.
41. Oberreuther-Moschner, D.L., Jahreis, G., Rechkemmer, G., Pool-Zobel, B.L. (2004), "Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29 clone 19A cells" in Br. J. Nutr., Vol. 91, pp. 925-932.
42. Orrhage, K., Sillerstrom, E., Gustafsson, J.A., Nord, C.E., Rafter, J. (1994), "Binding of mutagenic heterocyclic amines by intestinal and LAB" in Mutat. Res., Vol. 311, p. 239.
43. Rafter, L. (2002), "Lactic acid bacteria and cancer: mechanistic perspective" in Br. J. Nutr., Vol. 88, Suppl. 1, p. 89.
44. Rangavajhyala, N., Shahani, K.M., Sridevi, G., Srikumaran, S. (1997), "Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulates the production of interlukin-1α and tumor necrosis factor-α by murine macrophages" in Nutr. Cancer, Vol. 28, pp. 130-134.
45. Roos, N.M., Katan, M.B. (2000), "Effects of probiotic bacteria on diarrhea, lipid metabolism and carcinogenesis: a review of papers published between 1988 and 1998" in Am. J. Clin. Nutr., Vol. 71, pp. 405-411.
46. Rowland, I. (2004), "Probiotics and colorectal cancer risk: invited commentary" in Br. J. Nutr., Vol. 91, pp. 805-807.
47. Rowland, I.R., Rulley, C.J., Coutts, L.T., Lievense, L.C. (1998), "Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats" in Carcinogenesis, Vol. 19, pp. 281-285.
48. Saarela, M., Morgensen, G., Fondén, R., Matto, J., Mattila-Sandholm, T. (2000), "Probiotic bacteria: safety, functional and technological properties" in J. Biotechnol., Vol. 84, pp. 197-215.
49. Saavedra, J.M., Bauman, N.A., Oung, I., Perman, J.A., Yolken, R.H. (1994), "Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus" in Lancet, Vol. 344, pp. 1046-1049.
50. Saloff-Coste, C.J. (1995), "Fermented milks: effects on immune system" in Danone World Newsletter, No. 9, pp. 1-7.
51. Sanders, M.E., Huis in't Veld, J. (1999a), "Bringing a probiotic containing functional food to the market: microbiological, product, regulatory and labeling issues" in Antonie Leeuwenhoek, Vol. 76, pp. 293-315.
52. Sanders, M.E., Huis in't Veld, J. (1999b), "Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues" in Konings, W.N., Kuipers, O.P., Huis in't Veld, J. (Eds.), Proc. 6th Symp. Lactic Acid Bacteria: Genetics, Metabolisms and Applications, Kluwer, Amsterdam, pp. 293-315.
53. Sanders, M.E., Walker, D.C., Walker, K.M., Aoyama, K., Klaenhammer, T.R. (1996), "Performance of commercial cultures in fluid milk applications" in J. Dairy Sci., Vol. 79, pp. 943-955.
54. Schiffrin, E.J., Rochat, F., Link-Amster, H., Aeschlimann, J.M., Donnet-Hughes, A. (1995), "Immunomodulation of human blood cells following ingestion of lactic acid bacteria" in J. Dairy Sci., Vol. 78, pp. 491-497.
55. Sekine, K., Ohta, J., Onishi, M., Tatsuki, T., Shirnokawa, Y., Toida, T., Kawashima, T., Hashimoto, Y. (1995), "Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bijidobacterium infantis" in Biol. Pharm. Bull., Vol. 18, pp. 148-153.
56. Sepp, E. (1997), "Intestinal microflora of Estonian and Swedish infants" in Acta Paediatr., Vol. 86, pp. 956-961.
57. Shah, N. (1993), "Effectiveness of dairy products in alleviation of lactose intolerance" in Food Australia, Vol. 45, pp. 268-271.
58. Shalev, E., Batino, S., Weiner, E., Colodner, R., Keness, Y. (1996), "Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and vaginosis" in Arch. Family Med., Vol. 5, pp. 593-596.
59. Taylor, G.R.J., Williams, C.M. (1998), "Effects of probiotics and prebiotics on blood lipids" in Br. J. Nutr., Vol. 80, Suppl. 1, pp. S225-S230.
60. Tejada-Simon, M.V., Lee, J.H., Ustunol, Z., Pestka, J.J. (1999), "Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin a responses to cholera toxin in mice" in J. Dairy Sci., Vol. 82, pp. 649-660.
61. Vinderola, C.G., Bailo, N., Reinheimer, J.A. (2000a), "Survival of probiotic microflora in Argentinian yoghurts during refrigerated storage" in Int. Dairy J., Vol. 33, pp. 97-102.
62. Vinderola, C.G., Prosello, W., Ghiberto, D., Reinheimer, J.A. (2000b), "Viability of probiotic (Bifidobacterium, Lactobacillus acidophilus and Lactobacillus casei) and nonprobiotic microflora in Argentinian fresco cheese" in J. Dairy Sci., Vol. 83, pp. 1905-1911.
63. Wagner, R.D., Pierson, C., Warner, T., Dohnalek, M., Farmer, J., Roberts, L., Hilty, M., Balish, E. (1997), "Biotherapeutic effects of probiotic bacteria on candidiasis on immunodeficient mice" in Infect. Immun., Vol. 65, pp. 4165-4172.
64. Wollowski, I., Rechkemmer, G., Pool-Zobel, B.L. (2001), "Protective role of probiotics and prebiotics in colon cancer" in Am. J. Clin. Nutr., Vol. 73, Suppl. 2, pp. 451S-455S.
65. Wollowski, I., Bakalinsky, S.J.A., Neudecker, C., Pool-Zobel, B.L. (1999), "Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats" in J. Nutr., Vol. 129, p. 77.
66. Yamazaki, K., Tsiluloda, A., Sibusawa, M., Tsluloda, Y., Kusano, M., Fukuchi, K., Yamanaka, M., Kushima, M., Nomoto, K., Morotorni, M. (2000), "The effects of oral administration of Lactobacillus casei Shirota on azoxyrnethane-induced colonic aberrant crypt foci and colon cancer in rats" in Oncology Reports, Vol. 7, p. 977.
67. You, H.L., Oh, D.K., Ji, G.E. (2004), "Anticancerogenic effect of a novel chiroinositol containing polysaccharide from Bifidobacterium bifidum BGN4" in FEMS Microbiol. Lett., Vol. 240, pp. 131-136.
68. Young, G.P., Leu, R.K.L. (2002), "Preventing cancer: dietary lifestyle or clinical intervention" in Asia Pacific J. Clin. Nutr., Vol. II, Suppl., p. 618.
69. Zsivkovits, M., Fekadu, K., Sonlag, G., Nabiuger, U., Huber, W.W., Kuudi, M., Chakraborty, A., Foissy, H., Knasmüller, S. (2003), "Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus starins" in Carcinogenesis, Vol. 24, pp. 1913-1918.
70. Arimochi, H., Kinouchi, T., Kataoka, K., Kuwahara, T., Ohnishi, Y. (1997), "Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon" in Biochem. Biophys. Res. Com., Vol. 238, pp. 753-757.
71. Barefoot, S.F., Nettles, F.C.G., Chen, Y.R. (1994), "Lactacin B, a bacteriocin produced by Lactobacillus acidophilus" in DeVuyst, L. and Vandamme, E.J. (Eds.), Bacteriocins and Lactic Acid Bacteria, Chapman & Hall, London, pp. 353-376.
72. Gilliland, S.E. (1998), "Fermented milks and probiotics" in Marth, E.H. and Steele, J.L. (Eds.), Applied Dairy Microbiology, Marcel Dekker, New York, NY, pp. 195-212.
73. Goldin, B.R. (1998), "Health benefits of probiotics" in Br. J. Nutr., Vol. 80, Suppl. 2, pp. S203-S207.
74. Goldsby, R.A., Kindt, T.J. and Osborne, B.A. (Eds.) (2000), Immunology, Freeman and Company, New York, NY.
75. Gursoy, O., Kinik, O. (2006), "Probiotics: a new popular option for cancer inhibition" in Int. J. Dairy Sci., Vol. 1, No. 1, pp. 100-103.
76. Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G., Enk, A., Steinman, R.M., Romani, N., Schuler, G. (1996), "Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells" in Eur. J. Immunol., Vol. 26, pp. 659-664.
77. Hoesl, C.E., Altwein, L.E. (2005), "The probiotic approach: an alternative treatment option in urology" in European Urol., Vol. 47, No. 3, pp. 288-296.
78. Rincon, M., Anguita, J., Nakamura, T., Fikrig, E., Flavell, R.A. (1997), "Interleukin (IL)-6 directs the differentiation of IL-4 producing CD4+T cells" in J. Exp. Med., Vol. 185, pp. 461-467.
79. Rowland, I. (1999), "Probiotics and benefits to human health - the evidence in favor" in Environ. Microbiol., Vol. 1, pp. 375-382.
80. Sanders, M.E., Klaenhammer, T.R. (2001), "The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic" in J. Dairy Sci., Vol. 84, pp. 319-331.
81. Stanton, C., Gardiner, G., Lynch, P.B., Collins, J.K., Fitzgerald, G., Ross, R.P. (1998), "Probiotic cheese" in Int. Dairy J., Vol. 8, pp. 491-496.
82. Tannock, G. (Ed.) (2002), Probiotics and Prebiotics - Where Are We Going?, Caister Academic Press, Wymondham.
83. Vaughan, E.E., Mollel, B. (1999), "Probiotics in the new millenium" in Nahruug., Vol. 43, pp. 148-153.
84. Vinderola, C.G., Mocchiutti, P., Reinheimer, J.A. (2002), "Interactions among lactic acid starter and probiotic bacteria used for fermented dairy products" in J. Dairy Sci., Vol. 85, pp. 721-729.